4.7 Article

Association of Left Atrial Structure and Function With Heart Failure in Older Adults

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 79, 期 16, 页码 1549-1561

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2022.01.053

关键词

heart failure; left atrium; speckle tracking

资金

  1. National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]
  2. Actelion
  3. Alnylam
  4. Amgen
  5. AstraZeneca
  6. Bellerophon
  7. Bayer
  8. BMS
  9. Celladon
  10. Cytokinetics
  11. Eidos
  12. Gilead
  13. GSK
  14. Ionis
  15. Lilly
  16. Mesoblast
  17. MyoKardia
  18. NIH/NHLBI
  19. Neurotronik
  20. Novartis
  21. NovoNordisk
  22. Respicardia
  23. Sanofi Pasteur
  24. Theracos
  25. US2.AI
  26. [R01 HL126637]
  27. [K24 HL155813]
  28. [R01 HL141288]

向作者/读者索取更多资源

This study assessed the left atrial (LA) structure and function in older adults without prevalent heart failure (HF) and found that LA measures were associated with NT-proBNP and increased risk of incident HF or death. These measures, when added to traditional risk factors and NT-proBNP, improved the accuracy of predicting cardiovascular events.
BACKGROUND Limited data exist to characterize novel measures of left atrial (LA) structure and function in older adults without prevalent heart failure (HF). OBJECTIVES The aim was to assess reference range of LA measures, their associations with N-terminal pro-B-type natriuretic-peptide (NT-proBNP) and the related risk for incident HF or death. METHODS We analyzed LA structure (LA maximal [LAViMax] and minimal volume indexed by body surface area) and function (LA emptying fraction, LA reservoir, conduit, and contraction strain) in 4,901 participants from the ARIC (Atherosclerosis Risk In Communities) study (mean age 75 +/- 5 years, 40% male, and 19% Black) without prevalent HF. We assessed sex-specific 10th and 90th percentile ARIC-based reference limits in 301 participants free of prevalent cardiovascular disease, and related LA measures to NT-proBNP and incident HF or death (median follow-up of 5.5 years) in the whole ARIC cohort. RESULTS Approximately 20% of the overall population had LA abnormalities according to the ARIC-based reference limit. Each LA measure was associated with NT-proBNP and, except for LAViMax, with incident HF or death after multivariable adjustment (including left ventricular function and NT-proBNP). Results were consistent in participants with normal LAViMax (P for interaction > 0.05). LA measures were prognostic for both incident HF with preserved ejection fraction or death and incident HF with reduced ejection fraction or death. When added to HF risk factors and NT-proBNP (baseline C-statistics = 0.74) all LA measures, except for LAViMax, significantly enhanced the prognostic accuracy. CONCLUSIONS Novel measures of LA structure and function, but not standard assessment by LAViMax, are associated with increased risk of incident HF or death regardless of measures of left ventricular function and NT-proBNP. (C) 2022 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据